In the field of medicine, D-ribose is an important intermediate and starting material for various nucleosides, anti-tumor drugs, and other drugs. Nearly 50% of antiviral drugs used in clinical practic
Innovative drugs in China China's innovative pharmaceutical sector is experiencing explosive growth, with the number of approved drugs reaching a record high in 2025 and overseas licensing deals surpa
The new drug Culmerciclib has been launched Culmerciclib (brand name: Sitanicina®) is the first global triple inhibitor of CDK2/4/6, developed by Zhengda Tianqing under China Biopharmaceuticals. I
Domestic innovative drug market shows astonishing explosive growth T he Chinese innovative drug market has achieved a "miraculous" growth from 2016 to 2025: the market size surged from less than 10 bi
New drug development for MM: FDA draft leads the "deep remission" era On January 20, 2026, the FDA released a draft guideline explicitly designating Minimal Residual Disease (MRD) and Complete Respons
Adenosine, a naturally occurring nucleoside, has emerged as a focal point in the cosmetics industry due to its potential benefits for skin health. It demonstrates significant potential in anti-aging a
Comparative Analysis of Valine and dl-Valine Valine and dl-valine are closely related yet fundamentally distinct organic compounds, exhibiting significant differences in origin, structure, biologica
The official promulgation of the 2025 edition of the Chinese Pharmacopoeia marks a step forward for China's drug standard system towards a more scientific, rigorous and internationalized direction. Th
I. Chemical Raw Materials (Approximately 40-45% of Total Consumption) 1. Purified Terephthalic Acid (PTA) Production (Approximately 40-48% of Total Consumption) Application Share: Largest downstream a
About Berberine Hydrochloride Natural Extract Berberine Hydrochloride Natural Extract, as a core alkaloid raw material, holds a significant position in the pharmaceutical industry's intestinal-related